IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,348,717 | -4.0% | 39,174,000 | 0.0% | 0.43% | -9.3% |
| Q2 2023 | $39,966,498 | +8.0% | 39,174,000 | +6.5% | 0.47% | +8.2% |
| Q1 2023 | $37,005,818 | +56.6% | 36,774,000 | +71.1% | 0.44% | +78.8% |
| Q4 2022 | $23,632,820 | +7.8% | 21,495,000 | 0.0% | 0.24% | +3.8% |
| Q3 2022 | $21,916,000 | +77.3% | 21,495,000 | +87.0% | 0.24% | +90.3% |
| Q2 2022 | $12,364,000 | +13.7% | 11,495,000 | +24.7% | 0.12% | +17.0% |
| Q1 2022 | $10,874,000 | +4.1% | 9,221,000 | +0.4% | 0.11% | +9.3% |
| Q4 2021 | $10,442,000 | +764.4% | 9,181,000 | +818.1% | 0.10% | +870.0% |
| Q3 2021 | $1,208,000 | +0.8% | 1,000,000 | 0.0% | 0.01% | +11.1% |
| Q2 2021 | $1,198,000 | +5.8% | 1,000,000 | 0.0% | 0.01% | -10.0% |
| Q1 2021 | $1,132,000 | 0.0% | 1,000,000 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $1,132,000 | +15.7% | 1,000,000 | 0.0% | 0.01% | -11.1% |
| Q3 2020 | $978,000 | – | 1,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 37,725,000 | $44,872,000 | 1.86% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,839,000 | $5,831,000 | 0.53% |
| AQR Arbitrage LLC | 13,500,000 | $16,193,000 | 0.46% |
| Context Capital Management, LLC | 3,934 | $4,719,000 | 0.44% |
| Polar Asset Management Partners Inc. | 7,000,000 | $8,387,000 | 0.09% |
| Calamos Advisors LLC | 9,500,000 | $11,397,000 | 0.05% |
| LINDEN ADVISORS LP | 6,998,000 | $8,394,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 16,318,000 | $19,572,000 | 0.02% |
| Citadel Advisors | 68,788,000 | $82,290,000 | 0.02% |
| PUTNAM INVESTMENTS LLC | 7,564,000 | $8,997,000 | 0.01% |